Suppr超能文献

间质基质细胞的体外扩增。

Ex vivo expansion of mesenchymal stromal cells.

机构信息

Dipartimento di Ematologia ed Oncologia Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, P.le Sant' Onofrio, 4, 00165 Roma, Italy.

出版信息

Best Pract Res Clin Haematol. 2011 Mar;24(1):73-81. doi: 10.1016/j.beha.2010.11.002. Epub 2011 Feb 23.

Abstract

Mesenchymal stromal cells (MSCs) are adult multipotent cells that can be isolated from several human tissues. MSCs represent a novel and attractive tool in strategies of cellular therapy. For in vivo use, MSCs have to be ex vivo expanded in order to reach the numbers suitable for their clinical application. Despite being efficacious, the use of fetal calf serum for MSC ex vivo expansion for clinical purposes raises concerns related to immunization and transmission of zoonoses; the standardization of expansion methods, possibly devoid of animal components, such as those based on platelet lysate, are discussed in this paper. Moreover, this review focuses on the search of novel markers for the prospective identification/isolation of MSCs and on the potential risks connected with ex vivo expansion of MSCs, in particular that of their malignant transformation. Available tests to study the genetic stability of ex vivo expanded MSCs are also analyzed.

摘要

间充质基质细胞(MSCs)是可以从多种人体组织中分离出的成体多能细胞。MSCs 是细胞治疗策略中一种新颖且有吸引力的工具。为了在体内使用,MSCs 需要在体外进行扩增,以达到适合其临床应用的数量。尽管有效,但为了临床目的,使用胎牛血清进行 MSC 的体外扩增引起了与免疫和人畜共患病传播相关的担忧;本文讨论了可能不含动物成分(如基于血小板裂解物的方法)的扩增方法的标准化。此外,本综述还重点关注了用于 MSC 前瞻性鉴定/分离的新型标志物的研究,以及与 MSC 体外扩增相关的潜在风险,特别是其恶性转化的风险。还分析了用于研究体外扩增 MSC 遗传稳定性的现有测试。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验